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Abstract 
A key challenge for genome-wide association studies 
(GWAS) is to understand how single nucleotide 
polymorphisms (SNPs) mechanistically underpin 
complex diseases. While this challenge has been 
addressed partially by Gene Ontology (GO) 
enrichment of large list of host genes of SNPs 
prioritized in GWAS, these enrichment have not been 
formally evaluated. Here, we develop a novel 
computational approach anchored in information 
theoretic similarity, by systematically mining lists of 
host genes of SNPs prioritized in three adult-onset 
diabetes mellitus GWAS. The “gold-standard” is 
based on GO associated with 20 published diabetes 
SNPs’ host genes and on our own evaluation. We 
computationally identify 69 similarity-predicted GO 
independently validated in all three GWAS 
(FDR<5%), enriched with those of the gold-standard 
(odds ratio=5.89, P=4.81e-05), and these terms can 
be organized by similarity criteria into 11 groupings 
termed “biomolecular systems”. Six biomolecular 
systems were corroborated by the gold-standard and 
the remaining five were previously uncharacterized. 
http://lussierlab.org/publications/ITS-GWAS 
Introduction 
Single nucleotide polymorphism (SNP) arrays have 
been extensively used to predict how genetic variants 
are related to a single phenotype in genome-wide 
association studies (GWAS). Many methods have 
been developed to confirm these predictions. SNPs 
predicted by GWAS have been assessed with follow-
up studies and with biological models.  In contrast, 
the opposite has not been true. There is a paucity of 
validation studies exploring the predicted 
biomolecular functions associated with known SNPs. 
To properly evaluate these predicted biomolecular 
functions, a statistically significant number of 
annotated SNPs using a proper methodology are 
required. Three important considerations argue for 
the improvement of the accuracy and validation set of 
related annotations, or what we are calling 
“biomolecular systems”, predicted by the SNP array. 
First, biomolecular systems associated with complex 
diseases are poorly understood and remain largely 
without computational replication in a different 
dataset or biological validation. Current enrichment 
approaches have only been conducted with intragenic 
SNPs. Second, the existing GWAS can be leveraged 
at minimal additional expense to unveil additional 
knowledge. Finally, increasing availability of 
multiple, independent, and disease-specific SNP 
array datasets provides an excellent opportunity to 
analyze across related experiments. 
Others have previously conducted straight-forward 
Gene Ontology (GO) [1] enrichment studies over a 
limited number of host genes annotated to intragenic 
SNPs. Such single study predictions with an arbitrary 
number of prioritized SNPs are available through 
web-based tools [2]. However, these studies do not 
provide formal evaluations as to the optimal cutoff 
for the number of prioritized SNPs and their 
computational validation remains entirely “internal” 
to a single study, using empirical or theoretical 
statistics for correction of multiple comparisons. 
Additionally, others have found a large number of 
biomolecular systems in the intersection of gene 
expression and SNPs or interacting quantitative trait 
loci (QTLs) [3, 4]. Together, these results suggest 
that long lists of prioritized host genes (PHG) 
annotated to intragenic SNPs in expression arrays 
contain additional biological function information 
about diseases beyond that found in a top few SNPs. 
The limitation to these previous computational 
validation approaches is that they remain entirely 
“internal” to a single study and use empirical or 
theoretical statistics for multiple comparison 
correction rather than consider any recapitulation in 
new patient datasets or biological validation. In this 
paper, we propose that multiple GWAS focusing on 
the same complex disease phenotype may provide a 
means for “external” validation of the biomolecular 
systems predicted by enrichment studies in a single 
GWAS. 
However, to provide this evaluation, biomolecular 
functions and processes need to be replicated 
between GWAS. This is challenging as biomolecular 
functions and processes that  are systematically 
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Confirmation of FDR[GO1,3,4,7] by FDR[GO3,12,13] 
queried via Gene Ontology contains over 25,000 
distinct terms, organized in a directed acyclic graph 
in various depths. Because of the high dimensionality 
of GO, the enriched GO terms between two studies 
may be similar (e.g. parent-child) but not identical. 
One solution is to use Information Theoretic 
Similarity (ITS), which was originally applied to GO 
by Lord et al. to show consistency between sequence 
and annotation [5]. Lerman et al. have shown high 
concordance between functions inferred from 
similarity in GO and measured structure of proteins 
and functional similarity of proteins. We and others 
have also shown how biological systems similarity 
measured by ITS in GO can improve the accuracy of 
machine learning-based predictions of biological 
function for inadequately characterized genes [6]. 
These studies further support the accuracy of ITS and 
of “annotation transference” between sequence, 
structure, and function [7] 
We hypothesize that biomolecular functions and 
processes discovered in a meta-analysis of several 
GWAS can formally be “replicated in silico” in a 
separate independent GWAS and validated by a gold 
standard with no significant bias. This gold standard 
can be derived from known published disease 
specific genes and GO annotations. Secondly, we 
hypothesize that we can increase the number of 
accurate predictions of disease-related biomolecular 
functions and processes which are significantly 
validated in the second GWAS by studying its ITS in 
GO in addition to its exact GO overlap when 
compared to other independent GWAS. Third, we 
also hypothesize that we can organize the resulting 
specific biomolecular functions and processes into a 
smaller set of biomolecular systems using the 
similarity criteria between GO terms to discriminate 
between uncharacterized systems of a disease and 
those corroborated ones.  
In this proof of concept paper, we chose to focus our 
analysis on Adult Onset Diabetes Mellitus (AODM) 
as it is a particularly intricate multi-system disease 
with relatively low odds ratio (OR)  in individual 
SNPs in pathologic phenotypes. We also propose an 
original evaluation based on GO terms associated 
with known host genes of AODM’s SNPs. 
Methods  
Data Processing and Experimental Design Figure 
1 provides a schema and succinct description of the 
proposed methods and evaluation. GWAS Datasets 
and SNP’s Host Gene(s) In this study, we used three 
independent GWAS: The Wellcome Trust Case 
Control Consortium (WTCCC)[8], Finland - United 
State Investigation of NIDDM Genetics 
(FUSION)[9], and the Diabetes Genetics Initiative 
(DGI)[10]. To standardize the gene names, refflat.txt, 
kgalias.txt, and knowngene.txt were downloaded 
from the UCSC genome browser (Nov. 2007) [11] as 
well as the core data from the Human Genome 
Organizations (HUGO)’s Gene Nomenclature 
Committee (June 30, 2008). Gene Ontology 
annotation, structural files gene_ontology.obo (July 
08, 2008) and gene_annotation.goa_human.gz (Oct. 
28, 2008) were downloaded from its website [12]. 
SNP’s Host Gene(s) Detailed methods are described 
in the Suppl. Methods. 
Functional annotation of GWAS to GO (Fig. 1, 
Panel I) We conducted an enrichment study with GO 
functional annotations to prioritize biomolecular 
systems related to AODM using host genes annotated 
to intragenic SNPs that were prioritized statistically 
in a GWAS. We systematically evaluated several 
numbers of prioritized host genes (PHG) as follows, 
50, 100, 200, 300, 400, 500, or 1000. The unadjusted 
P-value of the GO enrichment was calculated using 
Figure 1.  Overall Experimental Design. Molecular 
functions and biological processes of GO are considered as 
measurements of biomolecular systems of diseases.  The 
approach is to determine GO terms that can be repeatedly 
found in three GWAS either by exact match or by 
similarity to other GO terms. The GO terms enriched in 
each of three GWAS  are extracted (I, upper panel); GO 
terms enriched in both of two GWAS are calculated based 
on (i) direct overlap of GO terms in both studies (baseline 
control, II.A), and on  (ii) information theoretic similarity 
(ITS) between GO terms of each studies (left side of 
middle panel, IIB).  In silico evaluation of the prediction of 
GO terms enriched in two studies are conducted in the 3
rd 
GWAS (right side of middle panel, IIB). Empirical 
estimates of false discovery rates (FDR) are generated via 
bootstraps (FDR of the in silico replication, II). Evaluation 
of predicted GO terms in three GWAS is performed using 
odds ratio based on a gold standard of Gene Ontology 
annotations of 20 published AODM SNP’s host-genes 
(III), Suppl. Methods). GOGWASi is the set of GO terms 
enriched at a certain P-value in the list of prioritized genes 
in GWAS “i”. 
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the cumulative hypergeometric distribution provided 
by an open source Perl API, GO-TermFinder[13]. 
Bonferroni correction (P-value*n,  where n=number 
of GO terms in the test) was applied to control for 
multiple comparisons. Hierarchical Refinement of 
Enriched GO Terms Recent reports have stated that 
enrichment studies conducted over genes in GO can 
generate falsely significant P-values due to the 
inheritance of genes in parent classes which may be 
highly enriched [14]. To remove such false positive 
signals inherited in the GO hierarchy during 
enrichment, we refined the enriched GO terms in 
each study according to each PHG with a novel set-
theoretic method described in the Supplemental 
Methods. 
Determining Similarity between GO Enriched 
GWAS  (Fig. 1, Panel II) In order to reduce the 
dimensionality of the predicted GO terms and to 
increase the precision, we retained only those terms 
that were either identical in two studies or similar 
between two studies. We previously implemented 
Lin’s standardized ITS metric [15] that ranges from 0 
to 1 to identify similarity between GO terms and have 
shown that an ITS score ≥ 0.7 was significant and 
optimal for the prediction of GO function in sparsely 
annotated genes[6]. GO terms enriched in each 
GWAS were systematically compared to one another 
using: (I) simple overlap (e.g. same GO terms or 
ITS=1, Fig. 1, Panel IIA), and with (II) GO terms 
with ITS ≥ 0.7 (Fig. 1, left side of Panel IIB), which 
are each from a distinct GWAS and with a similarity 
≥ 0.7 between them. Similar GO terms between two 
studies were also compared to the 3
rd GWAS for 
calculation of FDR and validation (Evaluation,  in 
silico replication in the 3
rd study, Fig. 1, right side 
of Panel IIB). With three GWAS, there were three 
possible combinations in which each study serves 
once as the validation study.  Each of these groups of 
predictions of related GO terms (biological processes 
and molecular functions) was controlled for with a 
FDR calculation using a bootstrap of randomly 
selected genes. 100 bootstraps were conducted for 
each of the GWAS at each prioritized host gene 
threshold and subjected to the same analyses (GO 
enrichment, hierarchical refinements, and ITS 
between GO of studies), to control for in silico 
replication (Fig. 1, right side of Panel IIB). Finally, 
GO terms with a similarity ≥ 0.7 among all three 
studies were also illustrated in a Cytoscape 
network[16] (Fig 2 and Suppl. Fig.1). 
Generation and Evaluation of Gold Standard (Fig. 
1, Panel III) To evaluate our predictions of GO 
terms  associated with AODM, we developed an 
“gold standard” with no significant bias based on GO 
annotations of 20 published diabetes genes [17]. Of 
the 20, 19 genes were annotated in GO generating 
245 distinct terms in what we call our “gold standard 
GO” (GS-GO). In addition, we conducted a study 
confirming that GO terms associated with these genes 
are more related to one another (and thus to diabetes) 
than an empirical distribution derived from 100 
bootstraps of a random pick of 19 host genes 
annotated in all three GWAS (P<0.0001; details in 
Suppl. Results). 
Results and Discussion 
  Reproducibility and Validation of Biomolecular 
Systems (Exact Overlap) We estimated the 
likelihood of a straightforward overlap of a specific 
enriched GO term in two or three studies. Table 1 
provides the number of overlapping GO terms 
enriched between FUSION and DGI GWAS 
(archetypical results, other   combinations of GWAS 
not shown) according to the following parameters: 
(I) P-value of GO enrichment adjusted for 
multiplicity and reproducibility in two studies, 
(II)  length of PHG. The large number of predicted 
GO does not satisfy statistical significance as 
measured by adjusted P-value or odds ratio with the 
gold standard. These drawbacks suggest that there is 
an opportunity for improving the accuracy of 
0.001 0.01 0.025 0.05 0.1 0.15 0.2 0.3
10
-6 0.002 0.038 0.306 1 1 1 1
50 0000 0 0 0 0
100 0000 1 346
200 0000 2 9 16 31
300 005 7 12 19 23 35
400 0 2 4 8 15 21 30 47
5 0 019 15 20 28 38 48 61
1000 7 14 21 35 49 58 67 83
0.002 0.249 1 1 1 1 1 1
50 0 136 6 8 10 14
100 0013 9 16 19 25
200 0014 1 7 23 39 51
300 3 8 17 23 30 34 37 54
400 4 6 14 18 32 43 59 81
5 0 0 51 22 02 9 4 3 59 74 106
1000 8 23 40 51 74 89 111 143
P
H
G
Intersectio
n of 
Enriched 
GO Sets in 
three 
GWAS
Intersectio
n of 
Enriched 
GO Sets in 
two GWAS
Unadjusted P
Adjusted P
P
H
G
Adjusted P
  
Table 1. Reproducibility of Biomolecular Systems 
predicted in GWAS through Exact GO overlap. This 
table presents the count of GO terms enriched in each 
GWAS according to the unadjusted P-value (top row) and 
that have been replicated in two (FUSION and DGI, lower) 
or three studies (upper). Further, different rows present 
results for increasing numbers of prioritized host genes 
(PHG) derived from GWAS intragenic SNPs. Joint P-
values for two and three GWAS were corrected with 
combinatorial Bonferroni correction ((P-value^
m)*n, 
m=number of GWAS, n=count of GO studied∼2800). Odds 
ratios were calculated from a gold standard of biomolecular 
results (see Methods). Legend: empty sets (0) are 
presented in pale grey (see Methods, bootstrap); struck, 
FDR>5% unshaded, meets Bonferroni corrections; bold 
and red, odds ratio>confidence interval 95% according to 
our gold standard. 
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predictions of replicated GO terms between two 
studies using similarity (for detail, see Suppl. 
Results and Suppl. Tables 1&2). 
Biomolecular Systems Predicted by ITS 
(Biological Similarity) In a sense, GO annotations 
serve as a proxy to identify components of 
biomolecular functions and processes that are then 
assembled in systems with similarity metric as well. 
Applying such an approach to uncharacterized SNPs 
is related to our previous work on predicting GO 
functions and processes in sparsely annotated genes 
[6] where we show that similarity could perform 
optimally in GO for values of ITS ≥0.7.  Table 2 
provides the number of similarity-predicted GO 
terms enriched between three independent GWAS 
(top) and between two GWAS, FUSION and DGI 
according to the following parameters: (I)  P-value of 
GO enrichment adjusted for multiplicity and 
reproducibility in multiple studies, (II)  length of 
PHG. As compared to the exact match study (Table 
1), we demonstrated that ITS has dramatically 
improved the accuracy of the predictions according to 
three metrics: (I) adjusted theoretical P≤0.05 (white 
zones, non-grey), (II) empirical FDR ≤5% (unstruck 
data), and (III)  statistically significant odds ratio 
using the GS-GO (Table 2, red bolded). The optimal 
range of prediction with high odds ratio is around 
200-300 PHG counts and at an unadjusted P-value of 
the GO enrichment (P=0.025). AS shown in Table 1, 
whether by exact match or by similarity, results 
between two studies are not statistically significant in 
most ranges as compared to those between three 
studies.  In contrast, there is a distinct improvement 
with ITS; the number of accurate predictions tripled 
and in some cases quintupled as compared to those 
found in the exact overlap method. These results 
suggest that ITS provide opportunities to uncover 
novel biomolecular systems properties overlooked by 
straightforward overlap methods. We also organized 
these GO terms as 11 biomolecular system classes by 
similarity to identify which of the GO terms found by 
similarity were novel as compared to those found by 
exact match (Figure 2). Cluster C, GTPase regulator 
activity, does not contain any black circles (exact 
match) and thus corresponds to a group of GO terms 
predicted exclusively by similarity. Further, Suppl. 
Figure 1 provides a more detailed map of GO terms 
where 6 “biomolecular systems” are corroborated by 
the gold standard (red circles) and five may be novel 
ones. Using ITS, the 69 GO terms that were similar 
among the three GWAS were also enriched in 
diabetes signal as they comprised 12 gold standards 
(GS-GO; P =4.81e-05, cumulative hypergeometric 
test). There was a significant fourfold increase in the 
number of predictions and a threefold increase in the 
recapitulation of our gold standard annotations.  At 
least four biomolecular systems were related to the 
nervous system, which may indicate a pleiotropy of 
biomolecular systems involved in complex traits. 
Although commonly thought as more of an endocrine 
organ, the endocrine pancreas responsible for 
secreting insulin and glucagon is a neuroendocrine 
organ with parasympathethic innervation. Further 
analysis is described in the Suppl. Results. 
Future Studies and Limitations We observed 
several limitations to this study. First, GO does not 
encompass pathophysiological and higher clinical 
concepts. Consequently, important associations with 
complex disease systems cannot be derived. Further, 
the gold standard we derived from all GO terms 
associated with diabetes SNPs is far from optimal 
and likely comprises GO terms not related to diabetes.  
In future studies, we will explore the use of 
expression arrays to derive an improved gold 
standard and also the use of eQTL associations in 
order to include intergenic SNPs via their “trans”- 
correlated genes in addition to their intragenic ones. 
We will use this approach to identify common 
systems across complex diseases. For example, one 
can imagine a study of metabolic syndrome by 
pooling hypertension diabetes, and cardiovascular 
studies along with obesity to generate the 
biomolecular systems underlying this complex 
disease. 
0.001 0.01 0.025 0.05 0.1 0.15 0.2 0.3
10
-6 0.002 0.044 0.35 1 1 1 1
50 00 0 0 0 2 2 8
100 00 0 0 10 30 35 54
200 00 10 38 53 70 90* 131*
300 0 2 17* 47 64 93 111 138
400 0 9 3 5 7 49 81 3 7 164 213
500 3 26 41* 81 131 143 187 237
1000 25 63* 107* 132 181 233 276 369
0.002 0.244 1 1 1 1 1 1
50 0 33 6 8 15 19 30*
100 00 41 2 2 945 54 79
200 0 71 8 39 61 87 116 134
300 4 16 32 53 67 88 108 137
400 4 14 42 75 103 138 173 221
500 8 25 37 79 129 156 198 261
1000 29 62 92 133 193 245 284 373
Unadjusted P
Enriched 
in GO 
terms in 
three 
GWAS 
related 
with ITS
Adjusted P
P
H
G
Enriched 
in GO 
terms in 
two GWAS 
related 
with ITS
Adjusted P
P
H
G
 
Table 2.  Reproducibility of Biomolecular Systems 
Predicted through Information Theoretic Similarity  
This table present the count of GO terms enriched in each 
GWAS using information theoretic similarity (ITS) between 
GO terms (ITS>0.7, Figure 1, Panel IIB). The lower table 
shows the number of GO terms predicted in two studies 
(FUSION and DGI) by ITS. The upper table is then 
associated with information theory to those of the WTCCC.  
Since a similarity of ITS=1 is the same thing as a join sets 
of GO (intersection of sets) produced in Table 1. Legend: 
see Table 1; *odds ratio significant in every combination of 
GWAS at that PHG and P-value. 
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Conclusion 
We successfully implemented a framework of 
functional similarity using Gene Ontology to more 
accurately recapitulate known biomolecular systems 
associations with complex diseases in GWAS 
according to a gold standard and to predict 
uncharacterized ones. We further show that this 
similarity technique is able to find more associations 
than a straightforward overlap of GO terms. 
Currently, a new biological process finds one host 
gene at a time through GWAS, which requires 
additional biological validation. To our knowledge, 
this is the first study that demonstrates reliable novel 
biological processes repeated across GWAS. Since 
very little is known of the biomolecular mechanisms 
relating SNPs to complex diseases and how these 
processes differ from those of single gene inheritance 
or from those observed in animal models, this 
approach could contribute in mapping the SNP 
phenome in high throughput and at low cost from 
existing studies, providing an insight into the genetic 
architecture underpinning the inheritable variants of 
complex diseases. 
(See  Supplementary Information for Additional 
References and Acknowledgements)  
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Figure 2. Biomolecular Systems of Adult Onset Diabetes 
Mellitus Discovered using Information Theoretic 
Similarity. 69 predicted GO terms are visually assembled 
in 11 distinct “biomolecular systems” using inter GO 
similarity. They are also enriched with 12 GO terms of the 
gold standard (P=4.81e-05, cumulative hypergeometric 
test). Predictions were conducted at ITS>0.7. Legend: The 
node presents GO terms and the edge between nodes 
indicates ITS relations. Increased line thickness 
corresponds with increased ITS (ITS of 1 indicates an exact 
GO match). Grey circles indicate ITS predicted GO terms. 
Black circles indicate 14 GO terms exactly overlap across 
three GWAS. Red rimmed circles correspond to 12 gold 
standard GO terms. Circle size indicates the number of 
GWAS contributing to the GO terms. Biomolecules 
Defined: A, voltage-gated ion channel activity; B, synapse 
(one is from biological process and the other is from 
molecular function); C, GTPase regulator; D, ion transport; 
E, membrane; F, receptor activity and neurotransmitter; G, 
signal transduction; H, Ras/Rho protein signal 
transduction;  I, ion binding; J, adhesion; K, glutamate 
receptor. (details in Suppl. Results, Suppl. Fig 1, Suppl. 
Tables 1&2) 
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